Literature DB >> 20677332

Non-viral causes of hepatocellular carcinoma.

Wojciech Blonski1, David S Kotlyar, Kimberly A Forde.   

Abstract

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and represents an international public health concern as one of the most deadly cancers worldwide. The main etiology of HCC is chronic infection with hepatitis B and hepatitis C viruses. However, there are other important factors that contribute to the international burden of HCC. Among these are obesity, diabetes, non-alcoholic steatohepatitis and dietary exposures. Emerging evidence suggests that the etiology of many cases of HCC is in fact multifactorial, encompassing infectious etiologies, comorbid conditions and environmental exposures. Clarification of relevant non-viral causes of HCC will aid in preventative efforts to curb the rising incidence of this disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20677332      PMCID: PMC2915420          DOI: 10.3748/wjg.v16.i29.3603

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  116 in total

1.  Coffee, alcohol, and the liver.

Authors:  D S Sharp; J E Everhart; N L Benowitz
Journal:  Ann Epidemiol       Date:  1999-10       Impact factor: 3.797

2.  Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.

Authors:  Manami Inoue; Itsuro Yoshimi; Tomotaka Sobue; Shoichiro Tsugane
Journal:  J Natl Cancer Inst       Date:  2005-02-16       Impact factor: 13.506

Review 3.  Coffee and cancer risk: an update.

Authors:  Carlo La Vecchia; Alessandra Tavani
Journal:  Eur J Cancer Prev       Date:  2007-10       Impact factor: 2.497

4.  Geographic variation of p53 mutational profile in nonmalignant human liver.

Authors:  F Aguilar; C C Harris; T Sun; M Hollstein; P Cerutti
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

5.  Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.

Authors:  H Tesluk; J Lawrie
Journal:  Arch Pathol Lab Med       Date:  1981-06       Impact factor: 5.534

Review 6.  Haemochromatosis in the new millennium.

Authors:  L W Powell; V N Subramaniam; T R Yapp
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

7.  Liver cell adenoma with malignant transformation: a case report.

Authors:  Masahiro Ito; Makoto Sasaki; Chun Yang Wen; Masahiro Nakashima; Toshihito Ueki; Hiromi Ishibashi; Michitami Yano; Masayoshi Kage; Masamichi Kojiro
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

8.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma.

Authors:  Masahiro Munaka; Kiyotaka Kohshi; Toshihiro Kawamoto; Shin Takasawa; Naoki Nagata; Hideaki Itoh; Susumu Oda; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2003-05-21       Impact factor: 4.553

9.  A meta-analysis of alcohol consumption and the risk of 15 diseases.

Authors:  Giovanni Corrao; Vincenzo Bagnardi; Antonella Zambon; Carlo La Vecchia
Journal:  Prev Med       Date:  2004-05       Impact factor: 4.018

10.  Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.

Authors:  Lihua Ming; Snorri S Thorgeirsson; Mitchell H Gail; Peixin Lu; Curtis C Harris; Nengjin Wang; Yongfu Shao; Zhiyuan Wu; Guoting Liu; Xiaohong Wang; Zongtang Sun
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

View more
  65 in total

1.  mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma.

Authors:  Hala Elnakat Thomas; Carol A Mercer; Larissa S Carnevalli; Jongsun Park; Jesper B Andersen; Elizabeth A Conner; Kazuhiro Tanaka; Tomoo Matsutani; Akio Iwanami; Bruce J Aronow; Liu Manway; S Michel Maira; Snorri S Thorgeirsson; Paul S Mischel; George Thomas; Sara C Kozma
Journal:  Sci Transl Med       Date:  2012-04-25       Impact factor: 17.956

2.  Hepatic loss in a young patient: a very 'cold case'.

Authors:  Vincenzo De Francesco; Enzo Ierardi; Giuseppe Stoppino; Fabrizio Corsi; Maria Rosaria D'Agnessa; Michele Castriota; Cesare Hassan; Francesco Cianci; Angelo Zullo
Journal:  Intern Emerg Med       Date:  2011-03-23       Impact factor: 3.397

3.  A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma.

Authors:  Masato Fujii; Yuichiro Shibazaki; Kyoko Wakamatsu; Yutaka Honda; Yusuke Kawauchi; Kenji Suzuki; Somasundaram Arumugam; Kenichi Watanabe; Takafumi Ichida; Hitoshi Asakura; Hiroyuki Yoneyama
Journal:  Med Mol Morphol       Date:  2013-02-22       Impact factor: 2.309

4.  Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.

Authors:  Vaibhav Chand; Akshay Pandey; Dragana Kopanja; Grace Guzman; Pradip Raychaudhuri
Journal:  Mol Cancer Res       Date:  2019-02-27       Impact factor: 5.852

5.  New players in non-alcoholic fatty liver disease induced carcinogenesis: lipid dysregulation impairs liver immune surveillance.

Authors:  Ngoc Lan Tran; Giovanni Sitia
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

6.  Hepatocellular carcinoma and industrial epidemics.

Authors:  Alain Braillon; Gérard Dubois
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

7.  Non-viral factors contributing to hepatocellular carcinoma.

Authors:  Manal A Hamed; Sanaa A Ali
Journal:  World J Hepatol       Date:  2013-06-27

Review 8.  The Ca(2+)/Calmodulin/CaMKK2 Axis: Nature's Metabolic CaMshaft.

Authors:  Kathrina L Marcelo; Anthony R Means; Brian York
Journal:  Trends Endocrinol Metab       Date:  2016-07-20       Impact factor: 12.015

9.  Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases.

Authors:  Chi-Pang Wen; Jie Lin; Yi Chen Yang; Min Kuang Tsai; Chwen Keng Tsao; Carol Etzel; Maosheng Huang; Chung Yi Hsu; Yuanqing Ye; Lopa Mishra; Ernest Hawk; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2012-10-17       Impact factor: 13.506

10.  Canadian trends in liver cancer: a brief clinical and epidemiologic overview.

Authors:  P De; D Dryer; M C Otterstatter; R Semenciw
Journal:  Curr Oncol       Date:  2013-02       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.